Is In8bio Stock a Good Investment?
In8bio Investment Advice | INAB |
- Examine In8bio's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research In8bio's leadership team and their track record. Good management can help In8bio navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact In8bio's business and its evolving consumer preferences.
- Compare In8bio's performance and market position to its competitors. Analyze how In8bio is positioned in terms of product offerings, innovation, and market share.
- Check if In8bio pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about In8bio's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in In8bio Inc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if In8bio Inc is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine In8bio Stock
Researching In8bio's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 22.0% of the company shares are held by company insiders. The book value of In8bio was currently reported as 0.58. The company recorded a loss per share of 0.74. In8bio Inc had not issued any dividends in recent years.
To determine if In8bio is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding In8bio's research are outlined below:
| In8bio Inc generated a negative expected return over the last 90 days | |
| In8bio Inc has high historical volatility and very poor performance | |
| In8bio Inc has some characteristics of a very speculative penny stock | |
| In8bio Inc has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (30.01 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| In8bio Inc currently holds about 25.74 M in cash with (23.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.37, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| In8bio Inc has a poor financial position based on the latest SEC disclosures | |
| Roughly 22.0% of the company shares are held by company insiders | |
| Latest headline from gurufocus.com: IN8bio Reports Continued Durable Remissions in Phase 1 Trial of INB-200 in Plenary Oral ... |
In8bio Quarterly Liabilities And Stockholders Equity |
|
In8bio uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in In8bio Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to In8bio's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact In8bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises In8bio's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-05-09 | 2024-03-31 | -0.18 | -0.2 | -0.02 | 11 | ||
2024-08-09 | 2024-06-30 | -0.168 | -0.19 | -0.022 | 13 | ||
2021-11-10 | 2021-09-30 | -0.28 | -0.25 | 0.03 | 10 | ||
2023-03-30 | 2022-12-31 | -0.32 | -0.37 | -0.05 | 15 | ||
2022-11-10 | 2022-09-30 | -0.29 | -0.34 | -0.05 | 17 | ||
2022-03-17 | 2021-12-31 | -0.26 | -0.21 | 0.05 | 19 | ||
2024-03-14 | 2023-12-31 | -0.15 | -0.21 | -0.06 | 40 | ||
2022-08-12 | 2022-06-30 | -0.29 | -0.38 | -0.09 | 31 |
Know In8bio's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as In8bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading In8bio Inc backward and forwards among themselves. In8bio's institutional investor refers to the entity that pools money to purchase In8bio's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Blackrock Inc | 2024-06-30 | 57.1 K | Rock Creek Group, Lp | 2024-06-30 | 52.4 K | Overbrook Management Corp | 2024-09-30 | 33.8 K | Northern Trust Corp | 2024-09-30 | 30 K | Lpl Financial Corp | 2024-09-30 | 12.3 K | Westside Investment Management, Inc. | 2024-06-30 | 12 K | Hrt Financial Llc | 2024-06-30 | 10.8 K | Hightower Advisors, Llc | 2024-06-30 | 10 K | Tower Research Capital Llc | 2024-06-30 | 3.8 K | Aigh Capital Management, Llc | 2024-09-30 | 1.7 M | Vanguard Group Inc | 2024-09-30 | 1.4 M |
In8bio's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 22.02 M.Market Cap |
|
In8bio's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.89) | (0.93) | |
| Return On Capital Employed | (1.07) | (1.12) | |
| Return On Assets | (0.89) | (0.93) | |
| Return On Equity | (1.20) | (1.14) |
Determining In8bio's profitability involves analyzing its financial statements and using various financial metrics to determine if In8bio is a good buy. For example, gross profit margin measures In8bio's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of In8bio's profitability and make more informed investment decisions.
Please note, the presentation of In8bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, In8bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of In8bio's management manipulating its earnings.
Evaluate In8bio's management efficiency
In8bio Inc has return on total asset (ROA) of (0.7764) % which means that it has lost $0.7764 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8045) %, meaning that it created substantial loss on money invested by shareholders. In8bio's management efficiency ratios could be used to measure how well In8bio manages its routine affairs as well as how well it operates its assets and liabilities. As of November 27, 2024, Return On Tangible Assets is expected to decline to -0.93. In addition to that, Return On Capital Employed is expected to decline to -1.12. At present, In8bio's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 687.7 K, whereas Total Assets are forecasted to decline to about 25.1 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.83 | 0.75 | |
| Tangible Book Value Per Share | 0.83 | 0.75 | |
| Enterprise Value Over EBITDA | (0.87) | (0.91) | |
| Price Book Value Ratio | 1.65 | 1.74 | |
| Enterprise Value Multiple | (0.87) | (0.91) | |
| Price Fair Value | 1.65 | 1.74 | |
| Enterprise Value | 24.8 M | 39.9 M |
Evaluating the management effectiveness of In8bio allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The In8bio Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Beta (0.07) |
Basic technical analysis of In8bio Stock
As of the 27th of November, In8bio owns the Information Ratio of (0.03), coefficient of variation of (4,604), and Market Risk Adjusted Performance of 0.205. In8bio Inc technical analysis makes it possible for you to employ past data patterns with the intention to determine a pattern that calculates the direction of the firm's future prices.In8bio's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific In8bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on In8bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases In8bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
In8bio's Outstanding Corporate Bonds
In8bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. In8bio Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most In8bio bonds can be classified according to their maturity, which is the date when In8bio Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US45674CAA18 Corp BondUS45674CAA18 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand In8bio's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing In8bio's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | 0.205 | |||
| Mean Deviation | 5.5 | |||
| Coefficient Of Variation | (4,604) | |||
| Standard Deviation | 12.3 | |||
| Variance | 151.25 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | (2.19) | |||
| Treynor Ratio | 0.195 | |||
| Maximum Drawdown | 109.03 | |||
| Value At Risk | (11.54) | |||
| Potential Upside | 6.67 | |||
| Skewness | 3.73 | |||
| Kurtosis | 25.68 |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | 0.205 | |||
| Mean Deviation | 5.5 | |||
| Coefficient Of Variation | (4,604) | |||
| Standard Deviation | 12.3 | |||
| Variance | 151.25 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | (2.19) | |||
| Treynor Ratio | 0.195 | |||
| Maximum Drawdown | 109.03 | |||
| Value At Risk | (11.54) | |||
| Potential Upside | 6.67 | |||
| Skewness | 3.73 | |||
| Kurtosis | 25.68 |
Consider In8bio's intraday indicators
In8bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of In8bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 22295.06 | |||
| Daily Balance Of Power | 0.5 | |||
| Rate Of Daily Change | 1.03 | |||
| Day Median Price | 0.31 | |||
| Day Typical Price | 0.31 | |||
| Price Action Indicator | 0.005 | |||
| Period Momentum Indicator | 0.01 |
In8bio Stock media impact
Far too much social signal, news, headlines, and media speculation about In8bio that are available to investors today. That information is available publicly through In8bio media outlets and privately through word of mouth or via In8bio internal channels. However, regardless of the origin, that massive amount of In8bio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of In8bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of In8bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to In8bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive In8bio alpha.
In8bio Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards In8bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
In8bio Corporate Management
| Pharm MPH | VP Communications | Profile | |
| TaiWei Ho | President, CoFounder | Profile | |
| William Ho | President, CoFounder | Profile | |
| Trishna MD | Chief Officer | Profile | |
| Kate Rochlin | Chief Officer | Profile | |
| Lawrence Lamb | CoFounder VP | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In8bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In8bio. If investors know In8bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In8bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.74) | Return On Assets (0.78) | Return On Equity (1.80) |
The market value of In8bio Inc is measured differently than its book value, which is the value of In8bio that is recorded on the company's balance sheet. Investors also form their own opinion of In8bio's value that differs from its market value or its book value, called intrinsic value, which is In8bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In8bio's market value can be influenced by many factors that don't directly affect In8bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between In8bio's value and its price, as these two are different measures arrived at by various means. Investors typically determine if In8bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In8bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.